BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 20, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 5, 2021
View Archived Issues
Qurient initiates phase II study of telacebec in moderate COVID-19
Read More
Enrollment opens in phase I study of LP-168 in relapsed or refractory B-cell malignancies
Read More
RGS10 gene mutations linked to combined immunodeficiency
Read More
Allergy Therapeutics reports findings from ex vivo biomarker study of VLP Peanut
Read More
FDA clears IND for [225Ac]PSMA I&T for mCRPC
Read More
PanTher receives ethics approval to initiate phase I study of PTM-101 in Australia
Read More
Merck & Co. identifies new arginase inhibitors
Read More
New MAP2K inhibitors discovered at Immuneering Corp.
Read More
GB-5001 demonstrates safety in toxicity study in dogs
Read More
The University of Washington and the Department of Veterans Affairs patent glycolysis inhibitors
Read More
New cyclophilin ligands described by Harvard College
Read More
Exosomes conjugated to VEGF antibodies show efficacy in models of choroidal neovascularization
Read More
Target engagement, safety seen with anti-TREM-2 monoclonal antibody AL-002 in healthy subjects
Read More
GWAS gives clues to menopause, and healthy aging
Read More
89Zr-Immuno-PET using bispecific Abeta MAb as promising diagnostic strategy for Alzheimer's disease
Read More
Updated results provided for ACI-24 in adults with Down syndrome
Read More
Telix initiates first-in-human study of next-generation prostate cancer therapy candidate TLX-592
Read More
Noema studies PDE10A inhibitor NOE-105 for Tourette's syndrome in phase IIa
Read More
KIR3DL3-HHLA2 pathway could be targeted for cancer immunotherapy
Read More
